ROCKLAGE SCOTT M — SEC insider filings

SEC reporting owner CIK 1219014. 39 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2020-10-07 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Skye Bioscience, Inc. (SKYE)10% owner72 legs · 5,656,074 sh · $16,526,03125 legs · 1,055,553 sh · $2,995,503—
Cabaletta Bio, Inc. (CABA)10% owner4—9 legs · 1,605,000 sh · $19,324,000—
Rallybio Corp (RLYB)10% owner51 leg · 615,384 sh · $7,999,9927 legs · 560,000 sh · $6,735,500—
Homology Medicines, Inc. (FIXX)10% owner2—6 legs · 1,000,000 sh · $12,535,915—
IDEAYA Biosciences, Inc. (IDYA)10% owner1—3 legs · 800,000 sh · $10,928,000—
Entrada Therapeutics, Inc. (TRDA)10% owner61 leg · 250,000 sh · $5,000,00013 legs · 531,285 sh · $4,068,04310
IMPEL NEUROPHARMA INC (IMPL)10% owner21 leg · 575,000 sh · $8,625,000—11
Akouos, Inc. (AKUS)10% owner2—2 legs · 470,000 sh · $8,460,0002
Pear Therapeutics, Inc. (PEAR)10% owner6—33 legs · 18,431,771 sh · $5,712,873—
scPharmaceuticals Inc. (SCPH)10% owner3—15 legs · 1,096,622 sh · $4,935,860—

+1 more issuer among the filings shown — every filing appears in the table below.

Insider filings — ROCKLAGE SCOTT M

FiledFormIssuerReported transactionsSource
2026-09-244Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Sale (S): 27,612 @ $1.65 · Sale (S): 1,088 @ $1.65 · Sale (S): 114,851 @ $1.61 · Sale (S): 4,528 @ $1.61EDGAR
2026-09-184Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Sale (S): 32,607 @ $1.91 · Sale (S): 1,285 @ $1.91EDGAR
2026-08-204Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Sale (S): 45,090 @ $0.38 · Sale (S): 1,830 @ $0.38 · Sale (S): 253,080 @ $0.38 · Sale (S): 10,255 @ $0.35 · Sale (S): 409 @ $0.35 · Sale (S): 57,476 @ $0.35 · +3 moreEDGAR
2026-08-104Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85EDGAR
2026-08-034Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85EDGAR
2025-11-184Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Sale (S): 200,000 @ $8.80EDGAR
2025-08-224Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Sale (S): 58,642 @ $3.57 · Sale (S): 2,314 @ $3.57 · Sale (S): 163,979 @ $3.42 · Sale (S): 6,470 @ $3.42EDGAR
2025-07-114Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50EDGAR
2025-07-014Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12EDGAR
2024-09-134Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Sale (S): 214,556 @ $6.60 · Sale (S): 36,504 @ $6.60 · Sale (S): 1,440 @ $6.60 · Sale (S): 11,758 @ $6.06 · Sale (S): 2,000 @ $6.06 · Sale (S): 79 @ $6.06EDGAR
2024-03-154Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Purchase (P): 450,000 @ $10EDGAR
2024-02-024Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH
Purchase (P): 5,206,074 @ $2.31EDGAR
2023-04-124Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 12,836,489 @ $0.12 · Sale (S): 534,855 @ $0.12 · Sale (S): 3,172,769 @ $0.12EDGAR
2023-03-094Rallybio Corp (RLYB)
jointly with 5AM Partners V, LLC, Schwab Andrew J., 5AM Ventures V, L.P.
Sale (S): 100,000 @ $8.20EDGAR
2022-12-024Akouos, Inc. (AKUS)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Code (U): 3,153,333 · Code (U): 982,453EDGAR
2022-11-154Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 28,205 @ $3.19 · Sale (S): 1,175 @ $3.19 · Sale (S): 11,643 @ $2.79 · Sale (S): 485 @ $2.79 · Sale (S): 61,222 @ $2.52 · Sale (S): 2,551 @ $2.52EDGAR
2022-11-024Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 40,477 @ $2.78 · Sale (S): 1,687 @ $2.78 · Sale (S): 1,408 @ $2.80 · Sale (S): 59 @ $2.80 · Sale (S): 10,155 @ $2.72 · Sale (S): 423 @ $2.72EDGAR
2022-10-114scPharmaceuticals Inc. (SCPH)
jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 30,457 @ $5.02 · Sale (S): 1,269 @ $5.02 · Sale (S): 5,808 @ $5.02 · Sale (S): 456,413 @ $4.09 · Sale (S): 19,017 @ $4.09 · Sale (S): 87,036 @ $4.09EDGAR
2022-09-164Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 273,664 @ $1.94 · Sale (S): 11,403 @ $1.94 · Sale (S): 261,840 @ $1.81 · Sale (S): 10,910 @ $1.81 · Sale (S): 337 @ $1.75 · Sale (S): 14 @ $1.75EDGAR
2022-09-084scPharmaceuticals Inc. (SCPH)
jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 21,702 @ $5.52 · Sale (S): 904 @ $5.52 · Sale (S): 4,016 @ $5.52 · Sale (S): 163,034 @ $4.75 · Sale (S): 6,793 @ $4.75 · Sale (S): 30,173 @ $4.75EDGAR
2022-09-084Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 298,714 @ $2.36 · Sale (S): 12,446 @ $2.36 · Sale (S): 148,337 @ $1.92 · Sale (S): 6,181 @ $1.92 · Sale (S): 292,149 @ $1.81 · Sale (S): 12,173 @ $1.81EDGAR
2022-08-184Pear Therapeutics, Inc. (PEAR)
jointly with 5AM Partners IV, LLC, 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 160,476 @ $1.78 · Sale (S): 6,686 @ $1.78 · Sale (S): 9,674 @ $1.71 · Sale (S): 403 @ $1.71 · Sale (S): 213,851 @ $1.55 · Sale (S): 8,910 @ $1.55EDGAR
2022-06-074Rallybio Corp (RLYB)
jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P.
Sale (S): 50,329 @ $12.50 · Sale (S): 99,671 @ $12.50EDGAR
2022-05-254Rallybio Corp (RLYB)
jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P.
Sale (S): 33,553 @ $13 · Sale (S): 66,447 @ $13EDGAR
2022-04-134scPharmaceuticals Inc. (SCPH)
jointly with 5AM Partners IV, LLC, 5AM Co-Investors IV, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Ventures IV, L.P., DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 220,096 @ $5 · Sale (S): 9,171 @ $5 · Sale (S): 40,733 @ $5EDGAR
2022-02-104Rallybio Corp (RLYB)
jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P.
Sale (S): 70,461 @ $13.05 · Sale (S): 139,539 @ $13.05EDGAR
2021-11-044Entrada Therapeutics, Inc. (TRDA)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Conversion (C): 318,616 · Conversion (C): 2,371,739 · Conversion (C): 564,217 · Conversion (C): 254,512 · Conversion (C): 318,140 · Purchase (P): 250,000 @ $20 · +5 moreEDGAR
2021-11-034Cabaletta Bio, Inc. (CABA)
jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J.
Sale (S): 258,456 @ $13 · Sale (S): 36,544 @ $13EDGAR
2021-09-094Cabaletta Bio, Inc. (CABA)
jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J.
Sale (S): 625,000 @ $9.70EDGAR
2021-08-044Rallybio Corp (RLYB)
jointly with 5AM Opportunities I, L.P., Schwab Andrew J., 5AM Opportunities I (GP), LLC, 5AM Partners V, LLC, 5AM Ventures V, L.P.
Purchase (P): 615,384 @ $13EDGAR
2021-04-294IMPEL NEUROPHARMA INC (IMPL)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J., 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC
Conversion (C): 808,259 · Conversion (C): 540,265 · Conversion (C): 500,932 · Conversion (C): 358,878 · Conversion (C): 101,457 @ $13.50 · Purchase (P): 575,000 @ $15 · +5 moreEDGAR
2021-04-264IMPEL NEUROPHARMA INC (IMPL)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J.
Other (J): 1,359,799.28 (derivative) @ $0EDGAR
2021-01-124Cabaletta Bio, Inc. (CABA)
jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J.
Sale (S): 264,589 @ $13 · Sale (S): 37,411 @ $13 · Sale (S): 74,470 @ $13 · Sale (S): 10,530 @ $13EDGAR
2020-12-314Akouos, Inc. (AKUS)
jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Schwab Andrew J.
Sale (S): 358,352 @ $18 · Sale (S): 111,648 @ $18EDGAR
2020-12-284Homology Medicines, Inc. (FIXX)
jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 480,000 @ $12.82 · Sale (S): 20,000 @ $12.82EDGAR
2020-12-164Homology Medicines, Inc. (FIXX)
jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 151,138 @ $13.06 · Sale (S): 328,862 @ $11.88 · Sale (S): 6,297 @ $13.06 · Sale (S): 13,703 @ $11.88EDGAR
2020-12-144Cabaletta Bio, Inc. (CABA)
jointly with 5AM Ventures V, L.P., 5AM Opportunities I (GP), LLC, 5AM Opportunities I, L.P., 5AM Partners V, LLC, PARMAR KUSH, Schwab Andrew J.
Sale (S): 261,084 @ $14.75 · Sale (S): 36,916 @ $14.75EDGAR
2020-11-134IDEAYA Biosciences, Inc. (IDYA)
jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, DIEKMAN JOHN D, Schwab Andrew J.
Sale (S): 657,117 @ $13.66 · Sale (S): 27,379 @ $13.66 · Sale (S): 115,504 @ $13.66EDGAR
2020-10-074Aprea Therapeutics, Inc. (APRE)
jointly with 5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, DIEKMAN JOHN D, Schwab Andrew J., PARMAR KUSH
Sale (S): 175,000 @ $25.30EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1219014 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs